2型糖尿病髋部骨折风险预测工具的开发与验证:Fremantle糖尿病研究I期
基于Fremantle糖尿病研究I期1251例2型糖尿病患者开发10年髋部骨折风险模型,并在Busselton健康研究286例中验证。模型含年龄、性别、BMI、周围感觉神经病变和eGFR<45,预测平均10年风险3.3%,判别力与校准良好,3%切点敏感度76.0%、特异度71.9%。
要点
- 模型仅用常规可获变量:年龄、性别、BMI、周围感觉神经病变、eGFR<45。
- 3%切点敏感度76.0%、特异度71.9%,阴性预测值98.6%。
- 外部验证样本较小但性能良好,敏感度66.7%、特异度79.8%。
核心结论
- FDS1髋部骨折风险方程是经过验证的简易工具,可辅助2型糖尿病管理。
研究设计与样本
- 纵向队列FDS1纳入1251例40-89岁2型糖尿病患者,随访至2012年底。
- 采用竞争风险回归建模确定10年首次髋部骨折的独立预测因素。
- 模型在Busselton健康研究286例2型糖尿病患者中外部验证。
主要发现
- 独立预测因素为年龄较大、女性、较低BMI、周围感觉神经病变和eGFR<45 mL/min/1.73 m2。
- 模型预测平均10年骨折风险3.3%,判别力、校准和准确性良好。
- 3%切点下敏感度76.0%、特异度71.9%、阳性预测值10.1%、阴性预测值98.6%。
- BHS验证敏感度66.7%、特异度79.8%、阳性预测值6.2%、阴性预测值99.2%。
关键数值与推荐
- 模型预测平均10年髋部骨折风险为3.3%。
- 3%切点下敏感度76.0%、特异度71.9%、阳性预测值10.1%、阴性预测值98.6%。
- BHS验证敏感度66.7%、特异度79.8%、阳性预测值6.2%、阴性预测值99.2%。
- QFracture在FDS1中表现良好但需25个变量。
临床怎么用
- 可将FDS1方程作为2型糖尿病管理的简易辅助工具,使用常规可获变量评估髋部骨折风险。
局限性
- 外部验证样本较小(BHS 286例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop a type 2 diabetes hip fracture risk tool in community-based patients, to validate it in an independent cohort, and to compare its performance against the only published prediction equation to include type 2 diabetes as a risk factor (QFracture). RESEARCH DESIGN AND METHODS: Hip fracture hospitalizations in 1,251 participants with type 2 diabetes aged 40-89 years from the longitudinal Fremantle Diabetes Study Phase I (FDS1) were ascertained between entry (1993-1996) and end-2012. Competing risk regression modeling determined independent predictors of time to first fracture over 10 years and the coefficients incorporated in a risk model. The model was validated in 286 participants with type 2 diabetes from the Busselton Health Study (BHS). RESULTS: Fifty FDS1 participants (4.0%) experienced a first hip fracture during 10,306 person-years of follow-up. Independent predictors of fracture were older age, female sex, lower BMI, peripheral sensory neuropathy, and estimated glomerular filtration rate <45 mL/min/1.73 m2. The model-predicted mean 10-year incident fracture risk was 3.3% with good discrimination, calibration, and accuracy. For a 3% cutoff, sensitivity was 76.0%, specificity 71.9%, positive predictive value (PPV) 10.1%, and negative predictive value (NPV) 98.6%. Model performance in the small BHS sample was also good (sensitivity 66.7%, specificity 79.8%, PPV 6.2%, and NPV 99.2%). QFracture performed well in FDS1 but required availability of 25 variables. CONCLUSIONS: The FDS1 hip fracture risk equation is a simple validated adjunct to type 2 diabetes management that uses variables that are readily available in routine care.
引用
- Davis WA, Hamilton EJ, Bruce DG, et al. Development and Validation of a Simple Hip Fracture Risk Prediction Tool for Type 2 Diabetes: The Fremantle Diabetes Study Phase I. Diabetes Care. 2018. PMID: 30455327. doi:10.2337/dc18-1486
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。